Skip to main content

Advertisement

SpringerLink
Log in

Screening

Screening for kidney disease—a lost opportunity

  • News & Views
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

The ACP has published 'weak' guidelines for screening patients for kidney disease based on limited or no data, which could harm patients with undiagnosed or progressive kidney disease. As kidney experts weren't involved in the development of these guidelines, what should all health professionals know about screening for kidney disease?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Qaseem, A., Hopkins, R., Sweet, D. E., Starkey, M. & Shekelle, P. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the Clinical Guidelines Committee of the American College of Physicians. Ann. Intern. Med. http://dx.doi.org/10.7326/0003-4819-159-12-201312170-00726.

  2. American Society of Nephrology. ASN emphasizes need for early detection of kidney disease, a silent killer [online], (2013).

  3. Susantitaphong, P. et al. World incidence of AKI: a meta-analysis. Clin. J. Am. Soc. Nephrol. 8, 1482–1493 (2013).

    Article  Google Scholar 

  4. Centers for Disease Control and Prevention. Prevalence of chronic kidney disease and associated risk factors—United States, 1999–2004. MMWR Morb. Mortal. Wkly Rep. 56, 161–165 (2007).

  5. United States Renal Data System. 2012 USRDS Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States [online], (2012).

  6. Murray, C. J. & Lopez, A. D. Measuring the global burden of disease. N. Engl. J. Med. 369, 448–457 (2013).

    Article  CAS  Google Scholar 

  7. American Academy of Family Clinicians. Screening chronic kidney disease [online], (2012).

  8. Moyer, V. A. et al. Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 157, 567–570 (2012).

    Article  Google Scholar 

  9. De Boer, I. H. et al. Screening for chronic kidney disease. Ann. Intern. Med. 158, 362–363 (2013).

    Article  Google Scholar 

  10. Qaseem, A. et al. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann. Intern. Med. 153, 194–199 (2010).

    Article  Google Scholar 

Download references

Acknowledgements

This article reflects the opinions of Bruce A. Molitoris, past president of the American Society of Nephrology (ASN). The ASN is currently drafting a more-comprehensive response to the American College of Physicians' guidelines on screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease.

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine, Indiana University School of Medicine, 950 West Walnut Street, R-2 202-C, Indianapolis, 46202, IN, USA

    Bruce A. Molitoris

Authors
  1. Bruce A. Molitoris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruce A. Molitoris.

Ethics declarations

Competing interests

The author is a FAST BioMedical founder, patent owner, partial owner and medical director.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Molitoris, B. Screening for kidney disease—a lost opportunity. Nat Rev Nephrol 10, 6–8 (2014). https://doi.org/10.1038/nrneph.2013.258

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2013.258

  • Springer Nature Limited

This article is cited by

Search

Navigation